Beyond Genomics and AstraZeneca to apply Systems Biology to Toxicology Study

Beyond Genomics, Inc. announced that it has entered into a pilot agreement with AstraZeneca to apply its Systems Biology expertise to the area of predictive toxicology.

Please to read the entire article.

You must be logged in to post a comment Login